Procyon Advisors’s Cardinal Health CAH Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q3
$6.36M Buy
28,577
+3,874
+16% +$901K 0.27% 91
2026
Q2
$5.87M Buy
24,703
+2,012
+9% +$418K 0.25% 94
2026
Q1
$4.79M Buy
22,691
+5,666
+33% +$1.22M 0.24% 106
2025
Q4
$3.5M Buy
17,025
+7,499
+79% +$1.41M 0.17% 121
2025
Q3
$1.5M Buy
+9,526
New +$1.47M 0.09% 181
2025
Q2
– Sell
-10,937
Closed -$1.51M – 491
2025
Q1
$1.51M Buy
+10,937
New +$1.39M 0.09% 212
2020
Q3
– Sell
-646
Closed -$34K – 325
2020
Q2
$34K Hold
646
– – 0.02% 444
2020
Q1
$31K Hold
646
– – 0.02% 399
2019
Q4
$33K Buy
+646
New +$33.4K 0.02% 405

Other funds holding CAH

Procyon Advisors's CAH Position: Q3 2026 in Review

Procyon Advisors increased its Cardinal Health (CAH) stake by 16% in Q3 2026, buying an estimated $901K and bringing the position to 28,577 shares worth $6.36M. The position accounts for 0.27% of the portfolio, ranked #91.

Procyon Advisors first reported a position in CAH in Q4 2019 and has held it in 9 quarters since. 510 funds tracked by Wall St. Rank hold CAH as of Q3 2026.

  • Procyon Advisors held 28,577 shares of Cardinal Health worth $6.36M as of Q3 2026.
  • Procyon Advisors bought 3,874 Cardinal Health shares in Q3 2026, an estimated $901K.
  • Cardinal Health made up 0.27% of Procyon Advisors's portfolio in Q3 2026, its #91 holding.
  • Procyon Advisors first reported a position in Cardinal Health in Q4 2019 and has held it in 9 quarters since.
  • 510 funds tracked by Wall St. Rank held Cardinal Health as of Q3 2026.

Based on Procyon Advisors's 13F filing for Q3 2026, filed 21 Oct 2026.